Intriguingly, increased expressions of ABCB6, BTG1 and EPB41L4B were found in glioma [37], thyroid carcinoma [38] and prostate cancer [39], respectively, but the underlying mechanism stays unclear. Here, ABCB6 is linked to central nervous system cancer.